AlixaRx has received a $100 million investment from Fillmore Capital Partners and be spun off from Drumm Corp., the companies said Monday.
(Oval) Office politics and private equity
By
John O'Connor
Jan 23, 2012
It was nearly four and a half years ago that The New York Times caused quite a stir in this sector. That’s when the self-proclaimed newspaper of record ran a largely unflattering piece about private...